Just as we predicted when the Biden “Inflation Reduction Act” was passed, the drug price controls have slowed medical innovation. UP senior fellow, Tomas Philipson wrote up his latest findings in the WSJ:
Just as we predicted when the Biden “Inflation Reduction Act” was passed, the drug price controls have slowed medical innovation. UP senior fellow, Tomas Philipson wrote up his latest findings in the WSJ: